Sharekhan

Aarti Pharmalabs Ltd

Fri 1/08/2025,15:53:22 NSE: AARTIPHARM

₹ 864.00 -47.20 (-5.18%)
BUY NOW Buy Aarti Pharmalabs Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Aarti Pharmalabs Ltd

Fri 1/08/2025,16:1:0

Aarti Pharmalabs Ltd

Fri 1/08/2025,15:53:22 | NSE : AARTIPHARM

₹ 864.00-47.20 (-5.18%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 911.20

Previous Close

₹ 911.20

Volume

305093

Mkt Cap ( Rs. Cr)

₹7830.83

High

₹ 918.35

Low

₹ 857.40

52 Week High

₹ 971.00

52 Week Low

₹ 557.05

Book Value Per Share

₹ 204.86

Dividend Yield

0.00

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Aarti Pharmalabs Ltd

Your Vote -

Buy

87.50%

Hold

0.00%

Sell

12.50%

87.50%

8 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

864.00

545

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

545

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aarti Pharmalabs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aarti Pharmalabs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:00AM As of June 2025, 43.72% is owned by Promoters and 56.28% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 43.55% and Forei

  • Aarti Pharmalabs - Credit Rating

    17 Jul 2025, 3:13PM Aarti Pharmalabs Limited has informed the Exchange about Credit Rating

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Credit Rating

    17 Jul 2025, 3:19PM Please find enclosed credit rating received from CRISIL Ratings Limited.

  • Aarti Pharmalabs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2025, 12:19PM Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Aarti Pharmalabs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2025, 12:16PM Certificate for the quarter ended June 30, 2025.

  • Aarti Pharmalabs - Disclosure under SEBI Takeover Regulations

    3 Jul 2025, 11:01PM Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (

  • Aarti Pharmalabs - Trading Window-XBRL

    25 Jun 2025, 4:59PM AARTI PHARMALABS LIMITED has informed the Exchange about Closure of Trading Window

  • Aarti Pharmalabs - Trading Window

    25 Jun 2025, 4:37PM Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Jun 2025, 3:58PM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    18 Jun 2025, 3:55PM Intimation of Earnings Conference Call

  • Aarti Pharmalabs - Updates

    27 May 2025, 3:17PM Aarti Pharmalabs Limited has informed the Exchange regarding 'Machine Readable copy of Financial Results for the quarter and financial year ended Marc

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    16 May 2025, 2:39PM Transcript of Q4/H2 FY25 Earnings Conference Call

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    16 May 2025, 2:39PM Aarti Pharmalabs Limited has informed the Exchange about Transcript

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    12 May 2025, 6:53PM Recording of the Earnings Conference call for Q4 FY 25

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    12 May 2025, 6:44PM Aarti Pharmalabs Limited has informed the Exchange about Link of Recording of Investor Meet

  • Aarti Pharmalabs - Outcome of Board Meeting-XBRL

    12 May 2025, 12:59PM Aarti Pharmalabs Limited has informed the Exchange regarding Outcome of Board Meeting held on 10-May-2025 for Dividend

  • Aarti Pharmalabs - Copy of Newspaper Publication

    12 May 2025, 12:32PM Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

  • Aarti Pharmalabs - Investor Presentation

    12 May 2025, 12:23PM Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 May 2025, 12:28PM Investor Presentation for Q4 FY 25

  • Aarti Pharmalabs - Grant Of Options Under PSOP Scheme 2023

    10 May 2025, 9:44PM Grant of options under the APL Performance Stock Option Plan 2023 (PSOP 2023)

  • Aarti Pharmalabs - ESOP/ESOS/ESPS

    10 May 2025, 9:41PM Aarti Pharmalabs Limited has informed the Exchange regarding Grant of 42000 Options.

  • Aarti Pharmalabs - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    10 May 2025, 9:37PM AARTI PHARMALABS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Ag

  • Aarti Pharmalabs Q4 net profit jumps 40.99% at Rs 88.85 cr

    10 May 2025, 7:40PM The company reported standalone net profit of Rs 88.85 crore for the quarter ended March 31, 2025 as compared to Rs 63.02 crore in the same period las

  • Aarti Pharmalabs - Dividend

    10 May 2025, 7:32PM Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on May 10, 2025, recommended Final Dividend of 2.50 per

  • Aarti Pharmalabs - Dividend

    10 May 2025, 7:30PM Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on May 10, 2025, recommended Final Dividend of Rs. 2.50

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Dividend Updates

    10 May 2025, 7:26PM Board Recommends the Final Dividend

  • Aarti Pharmalabs - Results For The Financial Year Ended 31.03.2025

    10 May 2025, 7:20PM Outcome of the Board Meeting and Results for the financial year ended 31.03.2025

  • Aarti Pharmalabs - Board Meeting Outcome for Outcome Of The Board Meeting Dated 10 May 2025

    10 May 2025, 7:13PM The Audited Financial Results and Statements of the Company (Standalone and\r\nConsolidated) for the Quarter and Year ended March 31, 2025, based on t

  • Aarti Pharmalabs - Outcome of Board Meeting

    10 May 2025, 7:04PM Aarti Pharmalabs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 10, 2025.

  • Aarti Pharmalabs - Analysts/Institutional Investor Meet/Con. Call Updates

    5 May 2025, 5:47PM Aarti Pharmalabs Limited has informed the Exchange about Schedule of meet on Monday, May 12, 2025 at 4:00 P.M. (IST) to discuss the Company's Q4-FY25/

  • Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    5 May 2025, 5:49PM This is to inform you that the Earnings Conference Call for Investors and Analysts,which would be a Group meet, has been scheduled on Monday, May 12,
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Aarti Pharmalabs Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2238.7261 1872.2571 1645.2909 1608.9004
Liabilities 2238.7261 1872.2571 1645.2909 1608.9004
Equity 45.3173 45.313 45.313 45.563
Gross Profit 426.5432 346.1585 308.3352 179.7858
Net Profit 257.3488 200.6454 171.7268 106.7261
Cash From Operating Activities 340.0057 183.6944 228.6894 -64.8426
NPM(%) 14.52 13.35 11.36 11.34
Revenue 1771.3517 1502.1319 1511.2478 941.021
Expenses 1344.8085 1155.9734 1202.9126 761.2352
ROE(%) 13.86 10.8 9.24 5.74

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
2.5 50 0 799.45
14 Feb 2025 2.5 50 0 636.3
31 Jul 2024 1 20 0 520.05
2 40 0 557.85

Peers

Other companies within the same industry or sector that are comparable to Aarti Pharmalabs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 1106.90 -2.69 23.78 8229.91 337.37 0.81
Amines and Plasticizers Ltd 227.60 0.61 30.55 5018.92 372.61 0.22
Indogulf Cropsciences Ltd 110.93 1.24 0.00 2145.38 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 33.31 41360.24 346.70 0.43

Company Info

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Our Company was incorporated as a public limited company under the Companies Act, 2013 in Gujarat, India pursuant to a certificate of incorporation dated November 22, 2019 issued by Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number (CIN) of the Company is U24100GJ2019PLC110964.Major events and milestone of our Company:2019Incorporation of the company. The Company had not commenced any business since its incorporation.2021The name of the Company was changed from `Aarti Organics Limited' to `Aarti Pharmalabs Limited'2022NCLT approved Scheme of Arrangement under the provisions of section 230 to 232 and other applicable provisions of the Companies Act, 2013 between Aarti Industries Limited and Aarti Pharmalabs Limited and their respective shareholders, sanctioned by the NCLT on September 21, 2022 (the certified true copy of the order was received on September 22, 2022). Pursuant to the Scheme, Pharma business of Aarti Industries Limited has been vested into the Company  2021 -Company name has changed to Aarti Pharmalabs Ltd. from Aarti Organics Ltd.

Read More

Parent Organisation

Aarti Pharmalabs Ltd.

Founded

22/11/2019

Managing Director

Mr.Narendra J Salvi

NSE Symbol

AARTIPHARMEQ

FAQ

The current price of Aarti Pharmalabs Ltd is ₹ 864.00.

The 52-week high for Aarti Pharmalabs Ltd is ₹ 918.35 and the 52-week low is ₹ 857.40.

The market capitalization of Aarti Pharmalabs Ltd is currently ₹ 7830.83. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Aarti Pharmalabs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Aarti Pharmalabs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarti Pharmalabs Ltd shares.

The CEO of Aarti Pharmalabs Ltd is Mr.Narendra J Salvi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT